| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.00094 | 1 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.00098 | 1 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.00087 | 1 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.00084 | 1 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.00093 | 1 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.00081 | 1 |